对《显性肝性脑病的经济负担及利福昔明的药物经济学影响的系统评价》的更正

Correction to: Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin.

作者信息

Neff Guy, Zachry Woodie

机构信息

Florida Research Institute, Florida Digestive Health Specialists, Lakewood Ranch, FL, USA.

Quantym Therapeutic Data, Sarasota, FL, USA.

出版信息

Pharmacoeconomics. 2018 Jul;36(7):881. doi: 10.1007/s40273-018-0676-8.

DOI:10.1007/s40273-018-0676-8

PMID:29856063

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5999159/

Abstract

The article Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin written by Guy Neff, Woodie Zachry was originally published electronically on the publisher's internet portal (currently Springer Link) on April 12, 2018 without open access.

摘要

盖伊·内夫、伍迪·扎克里撰写的《显性肝性脑病经济负担及利福昔明药物经济学影响的系统评价》一文最初于2018年4月12日在出版商的互联网门户网站（现为施普林格链接）上以电子形式发表，未开放获取。